Gyre Therapeutics, Inc. (GYRE)

NASDAQ

$6.10

$-0.31

(-4.85%)

Pre-Market

Gyre Therapeutics, Inc. (GYRE) Live Price Chart

Last updated: ⁦2026-10-20 08:48:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Gyre Therapeutics, Inc. (GYRE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.10, with a market capitalization of $644.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.44 to $9.14. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$644.69M
Open	$6.41
Day's High	$30.40
Day's Low	$5.44
Previous Close	$6.09
Volume	2.00
Average Volume	112.86K
P/E Ratio	--
52-Week High	$9.14
52-Week Low	$5.44
Dividend Yield	--
Earnings Date	--

Gyre Therapeutics, Inc. (GYRE) Pre-Market Stock Price

Gyre Therapeutics, Inc. (GYRE) is trading at $6.10 in pre-market trading as of 2026-10-20 08:40:00, up 0.18% ($0.01) from the previous close of $6.09

Pre-market trading shows how investors are pricing GYRE before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Gyre Therapeutics, Inc. (GYRE) 7-Day Stock Price Change

Over the past seven days, Gyre Therapeutics, Inc. (GYRE) moved from $7.04 to $6.10, representing a decline of 13.34% ($0.94).

The stock traded between $6.04 and $7.09 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 111.15 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

GYRE 52-Week Price Position

Position in Range: 17.9%

52W Low$5.44

52W High$9.14

GYRE is currently trading at $6.10, placing it 17.9% of the way from its 52-week low of $5.44 to its 52-week high of $9.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Gyre Therapeutics, Inc. (GYRE)?

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	618
Exchange	NASDAQ
Company Website	https://www.gyretx.com

How to Buy Gyre Therapeutics, Inc. (GYRE) Stock on MEXC

Eligible investors can buy real shares of Gyre Therapeutics, Inc. (GYRE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GYRE and Place Your Order

Open the RealStocks trading page and search for GYRE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Gyre Therapeutics, Inc. (GYRE) stock price today?

Gyre Therapeutics, Inc. (GYRE) is currently trading at $ 6.10, up 0.18% ($0.01) from the previous close of $ 6.09. Intraday prices update in real time during regular trading hours.

2.Is GYRE stock going up or down today?

As of 2026-10-20 08:40:00, GYRE is trading at $ 6.10, up 0.18% ($0.01) from its previous close of $ 6.09. The stock has traded between $ 5.44 and $ 30.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is GYRE pre-market price?

As of 2026-10-20 08:40:00, GYRE is trading at $ 6.10 in pre-market trading, up 0.18% ($0.01) from the previous close of $ 6.09. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GYRE after-hours price?

As of 2026-10-20 08:40:00, GYRE is trading at $ 6.37 in after-hours trading, up 4.60% ($0.28) from the regular-session close of $ 6.09. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GYRE stock trading now?

GYRE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GYRE sit relative to its 52-week high and low?

Over the past 52 weeks, GYRE has traded between a low of $ 5.44 and a high of $ 9.14. At $ 6.10, the stock is positioned 17.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Gyre Therapeutics, Inc. in?

Gyre Therapeutics, Inc. (GYRE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Gyre Therapeutics, Inc.'s market capitalization and where is it listed?

Gyre Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 644.69M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GYRE valued in terms of P/E ratio and EPS?

GYRE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.17. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Gyre Therapeutics, Inc. pay a dividend?

Gyre Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.